Roflumilast topical cream (Arcutis)

罗氟司特乳膏剂（Arcutis）

Report date: 2026/02/04 14:59:13

Base Information

Drug NameRoflumilast topical cream (Arcutis)
Drug Alias Name罗米司特乳膏剂（Arcutis）罗弗司特乳膏剂（Arcutis）罗氟斯特乳膏剂（Arcutis）ZORYVE creamARQ-151 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsPlaque psoriasisPsoriasisEczema +[4] 
Global Approved IndicationsPlaque psoriasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2022/07/29
Country/TerritoryCanadaUnited StatesDominican Republic +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesArcutis Inc
China Registration ClassN/A

Develop Information

Active CompaniesArcutis Biotherapeutics IncSato Pharmaceutical Co LtdHangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisPsoriasisEczema +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeR03DX07
Related LinksN/A